Filing Details

Accession Number:
0000096943-23-000110
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-29 17:43:42
Reporting Period:
2023-12-27
Accepted Time:
2023-12-29 17:43:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
96943 Teleflex Inc TFX Surgical & Medical Instruments & Apparatus (3841) 231147939
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1552476 Liam Kelly 550 E. Swedesford Road
Wayne PA 19087
Chairman, President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-27 23,175 $101.12 41,645 No 4 M Direct
Common Stock Acquisiton 2023-12-27 3,081 $107.47 44,726 No 4 M Direct
Common Stock Disposition 2023-12-27 23,585 $250.12 21,141 No 4 S Direct
Common Stock Disposition 2023-12-27 2,671 $251.16 18,470 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option / (Right to Buy) Disposition 2023-12-27 23,175 $0.00 23,175 $101.12
Common Stock Stock Option / (Right to Buy) Disposition 2023-12-27 3,081 $0.00 3,081 $107.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-02-26 No 4 M Direct
0 2024-04-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 19,317 Indirect By Helen Kelly 2021 Irrevocable Trust
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $250.00 to $250.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $251.00 to $251.525. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Exercisable for one-third of the shares on each of 2/26/2015, 2/26/2016 and 2/26/2017.
  4. Exercisable for one-third of the shares on each of 4/1/2015, 4/1/2016 and 4/1/2017.